| Literature DB >> 29364177 |
José Ignacio Cuitún Coronado1, Tarani Chandola2, Andrew Steptoe3.
Abstract
Although associations between work stressors and stress-related biomarkers have been reported in cross-sectional studies, the use of single time measurements of work stressors could be one of the reasons for inconsistent associations. This study examines whether repeated reports of work stress towards the end of the working career predicts allostatic load, a measure of chronic stress related physiological processes. Data from waves 2 to 6 of the English Longitudinal Study of Ageing (ELSA) were analysed, with a main analytical sample of 2663 older adults (aged 50+) who had at least one measurement of effort-reward imbalance between waves 2-6 and a measurement of allostatic load at wave 6. Cumulative work stress over waves 2-6 were measured by the effort-reward imbalance model. ELSA respondents who had reported two or more occasions of imbalance had a higher (0.3) estimate of the allostatic load index than those who did not report any imbalance, controlling for a range of health and socio-demographic factors, as well as allostatic load at baseline. More recent reports of imbalance were significantly associated with a higher allostatic load index, whereas reports of imbalance from earlier waves of ELSA were not. The accumulation of work related stressors could have adverse effects on chronic stress biological processes.Entities:
Keywords: allostatic load; effort-reward imbalance; lifecourse; work stress
Mesh:
Substances:
Year: 2018 PMID: 29364177 PMCID: PMC5857048 DOI: 10.3390/ijerph15020191
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Distribution of the allostatic load index component biomarkers at waves 2 and 6.
| Cut off for AL Index | |||||
|---|---|---|---|---|---|
| Wave 6 Allostatic Load Biomarkers | Mean/% | SD | Women | Men | |
| Cortisol (pg/mL) | 46.9 | 201.9 | 947 | >21.9 | >18.5 |
| Cortisone (pg/mg) | 8.5 | 9.0 | 956 | >7.6 | >11.5 |
| Insulin growth factor 1 (nmol/L) | 17.1 | 4.9 | 2640 | <13 | <15 |
| Pulse rate (beats per minute) | 54.7 | 12.2 | 2638 | >67.5 | >66.5 |
| White blood cell (×109 cells/L) | 6.3 | 1.8 | 2614 | >7.42 | >7.63 |
| C-reactive protein (mg/L) | 2.0 | 1.9 | 2539 | >3 | >2.6 |
| Fibrinogen (g/L) | 2.9 | 0.5 | 2561 | >3.3 | >3.2 |
| Total cholesterol to HDL ratio | 3.6 | 1.1 | 2648 | >3.89 | >4.46 |
| Triglycerides (mmol/L) | 1.5 | 0.9 | 2650 | >1.7 | >1.9 |
| Hba1c (%) | 40.0% | 7.1 | 2613 | >42 | >43 |
| Systolic blood pressure (mmHg) | 132.6 | 17.2 | 2638 | >145.5 | >147 |
| Diastolic blood pressure (mmHg) | 76.9 | 10.2 | 2638 | >81.5 | >82.5 |
| Anti-hypertensive medication | 21.0% | - | 2663 | ||
| Waist to height ratio | 0.6 | 0.1 | 2641 | >0.6325 | >0.6327 |
| Underweight (%) | 0.7% | - | 2628 | <18.5 | <18.5 |
| 2.6 | 2.0 | 2663 | |||
| Pulse rate (beats per minute) | 54.1 | 11.5 | 1020 | >69 | >68 |
| C-reactive protein (mg/L) | 2.1 | 2.1 | 968 | >3.7 | >3.2 |
| Fibrinogen (g/L) | 3.0 | 0.6 | 999 | >3.7 | >3.5 |
| Total cholesterol to HDL ratio | 4.0 | 1.0 | 1013 | >4.44 | >4.85 |
| Triglycerides (mmol/L) | 1.8 | 1.2 | 1014 | >2.1 | >2.3 |
| Hba1c (mmol/mol) | 36.1 | 6.2 | 1007 | >38.8 | >39.9 |
| Systolic blood pressure (mmHg) | 132.2 | 17.3 | 1020 | >149 | >148 |
| Diastolic blood pressure (mmHg) | 77.7 | 10.7 | 1020 | >82.5 | >84 |
| Anti-hypertensive medication | 8.2% | - | 1020 | ||
| Waist to height ratio | 0.6 | 0.1 | 1009 | >0.6214 | >0.6289 |
| Underweight (%) | 0.5% | - | 1003 | <18.5 | <18.5 |
| 1.7 | 1.6 | 1020 | |||
Figure 1Derivation of main analytical sample and subsample with wave 2 allostatic load measured from English Longitudinal Study of Ageing (ELSA) wave 6 nurse visit sample.
Distribution of wave 6 allostatic load (AL) index and covariates by cumulative effort-reward imbalance among ELSA participants.
| Wave 6 Variables | Cumulative Effort-Reward Imbalance | ||
|---|---|---|---|
| No Report | One Report | Two or More Reports | |
| Mean (SD)/% | Mean (SD)/% | Mean (SD)/% | |
| | 1403 | 717 | 543 |
| 2.45 (1.90) | 2.63 (2.07) | 2.91 (1.97) | |
| Men | 53% | 52% | 47% |
| Women | 47% | 48% | 53% |
| 50–54 | 10% | 17% | 1% |
| 55–59 | 21% | 26% | 36% |
| 60–64 | 28% | 29% | 40% |
| 65–69 | 26% | 20% | 19% |
| 70–74 | 11% | 6% | 3% |
| 75+ | 4% | 2% | 1% |
| White British | 97% | 98% | 97% |
| Non-white | 3% | 2% | 3% |
| Professional | 44% | 40% | 32% |
| Intermediate | 15% | 11% | 11% |
| Small employers | 14% | 14% | 10% |
| Lower & technical | 5% | 10% | 13% |
| Semi-routine & routine | 21% | 25% | 34% |
| Employed | 52% | 60% | 71% |
| Retired | 44% | 35% | 28% |
| Disabled/looking after family | 4% | 5% | 2% |
| No | 91% | 88% | 88% |
| Yes | 9% | 12% | 12% |
| Excellent/good | 90% | 85% | 78% |
| Fair/poor | 10% | 15% | 22% |
| 0 meds. | 39% | 35% | 32% |
| 1–2 meds. | 30% | 32% | 33% |
| 3–5 meds. | 22% | 22% | 25% |
| ≥6 meds. | 9% | 10% | 10% |
| CESD score < 4 | 95% | 91% | 87% |
| CESD score ≥ 4 | 5% | 9% | 13% |
| <once a week | 30% | 27% | 28% |
| Once a week | 12% | 10% | 13% |
| 1–3 times a month | 12% | 12% | 11% |
| Never | 47% | 51% | 48% |
| <once a week | 73% | 73% | 74% |
| Once a week | 16% | 14% | 13% |
| 1–3 times a month | 5% | 6% | 6% |
| Never | 5% | 8% | 7% |
| Almost every day | 16% | 14% | 14% |
| 5–6 days a week | 8% | 6% | 6% |
| 3–4 days a week | 20% | 18% | 13% |
| 1–2 a week | 24% | 29% | 28% |
| 1–2 a month | 12% | 13% | 14% |
| Once in 2 months | 7% | 6% | 6% |
| 1–2 times a year | 6% | 8% | 9% |
| Never | 7% | 5% | 9% |
Survey weighted regression model coefficient estimates (and 95% CI) of wave 6 allostatic load systems regressed on cumulative effort-reward imbalance.
| Wave 6 Allostatic Load (AL) System | Cumulative Effort-Reward Imbalance (Ref.: No Report) | |
|---|---|---|
| One Report | Two or More Reports | |
| Sympathoadrenal 1,2 | 0.09 (−0.04, 0.22) | 0.11 (−0.02, 0.24) |
| 0.187 | 0.105 | |
| Immune 1,2 | 0.11 (−0.02, 0.24) | 0.16 (0.02, 0.29) |
| 0.107 | 0.025 | |
| Metabolic 1,2 | 0.08 (−0.05, 0.21) | 0.10 (−0.04, 0.23) |
| 0.206 | 0.152 | |
| Cardiovascular 1,2 | 0.01 (−0.11, 0.13) | 0.11 (−0.01, 0.23) |
| 0.859 | 0.081 | |
| Anthropometric 1,3 | −0.05 (−0.30, 0.21) | 0.06 (−0.21, 0.33) |
| 0.727 | 0.670 | |
| Overall AL index 1,4 | 0.08 (0.003, 0.16) | 0.13 (0.05, 0.21) |
| 0.042 | 0.001 | |
1 Models control for all the covariates listed in Table 2, 2 Poisson model, 3 logit model, and 4 negative binomial regression models.
Survey weighted negative binomial regression coefficients (and 95% CI) of wave 6 allostatic load index regressed on effort-reward imbalance, effort, and reward at ELSA waves 2–6 1.
| ERI Measured at | Coeff. (95% CI) | |
|---|---|---|
| Wave 2 | 0.03 (−0.06, 0.12) | 0.476 |
| Wave 3 | −0.03 (−0.12, 0.06) | 0.487 |
| Wave 4 | 0.04 (−0.05, 0.12) | 0.368 |
| Wave 5 | 0.09 (−0.002, 0.17) | 0.055 |
| Wave 6 | 0.13 (0.03, 0.22) | 0.008 |
1 Models control for all the covariates listed in Table 2.
Survey weighted Poisson regression coefficients (and 95% CI) of wave 6 allostatic load index regressed on cumulative effort-reward imbalance, wave 6 covariates, and wave 2 allostatic load index: ELSA analytical subsample (n = 1020).
| Coeff. (95% CI) | Coeff. (95% CI) | ||||
|---|---|---|---|---|---|
| One report of ERI | 0.04 (−0.06, 0.13) | 0.434 | Once a week | 0.06 (−0.08, 0.19) | 0.423 |
| Two or more reports of ERI | 0.11 (0.01, 0.22) | 0.037 | 1–3 times a month | 0.06 (−0.09, 0.22) | 0.417 |
| AL index at W2 | 0.18 (0.16, 0.21) | <0.001 | Never | 0.06 (−0.05, 0.17) | 0.289 |
| Intermediate | 0.04 (−0.09, 0.17) | 0.577 | Once a week | 0.08 (−0.03, 0.19) | 0.141 |
| Small employers | 0.09 (−0.04, 0.22) | 0.160 | 1–3 times a month | 0.15 (−0.01, 0.30) | 0.067 |
| Lower & technical | 0.05 (−0.10, 0.20) | 0.529 | Never | 0.07 (−0.08, 0.23) | 0.340 |
| Semi-routine & routine | 0.08 (−0.02, 0.19) | 0.132 | |||
| 5–6 days a week | −0.11 (−0.29, 0.08) | 0.271 | |||
| Retired | −0.02 (−0.11, 0.08) | 0.721 | 3–4 days a week | −0.07 (−0.21, 0.08) | 0.371 |
| Sick-Disable/family carer | 0.04 (−0.13, 0.21) | 0.659 | 1–2 a week | −0.09 (−0.22, 0.04) | 0.170 |
| 1–2 a month | 0.03 (−0.12, 0.18) | 0.682 | |||
| Men | −0.13 (−0.26, −0.01) | 0.040 | Once in 2 months | −0.03 (−0.22, 0.16) | 0.742 |
| 1–2 times a year | 0.11 (−0.05, 0.27) | 0.176 | |||
| 55–59 | Never | 0.03 (−0.12, 0.18) | 0.690 | ||
| 60–64 | 0.06 (−0.06, 0.18) | 0.316 | |||
| 65–69 | −0.12 (−0.30, 0.06) | 0.204 | CESD score ≥ 4 | −0.05 (−0.21, 0.12) | 0.590 |
| 70–74 | 0.01 (−0.27, 0.29) | 0.957 | Intercept | 0.42 (0.23, 0.62) | <0.001 |
| 75+ | |||||
| Men aged 55–59 | |||||
| Men aged 60–64 | |||||
| Men aged 65–69 | 0.04 (−0.14, 0.22) | 0.636 | |||
| Men aged 70–74 | 0.39 (0.15, 0.63) | 0.001 | |||
| Men aged 75+ | 0.30 (−0.05, 0.66) | 0.091 | |||
| Non-White ethnic group | 0.10 (−0.17, 0.37) | 0.487 | |||
| Yes | 0.07 (−0.06, 0.21) | 0.279 | |||
| Fair/poor | 0.07 (−0.04, 0.18) | 0.243 | |||
| 1–2 meds. | 0.11 (−0.01, 0.22) | 0.079 | |||
| 3–5 meds. | 0.16 (0.04, 0.29) | 0.012 | |||
| ≥6 meds. | 0.19 (0.04, 0.34) | 0.012 | |||
* Interaction term of gender and age-group.
Figure 2Predicted levels of allostatic load (AL) at wave 6 (and 95% confidence intervals) by cumulative effort-reward imbalance (ERI): (a) estimates from main analytical sample (n = 2663) displayed in Supplementary Table S1; (b) estimates from analytical subsample (n = 1020) displayed in Table 5.